RLAY- Relay Therapeutics, Inc.

Name: Relay Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Relay Therapeutics, Inc. (RLAY) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. RLAY is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Patel Sanjiv	1.45M	$18.50M	-
Dir	Mazumdar Claire	421.2K	$5.38M	-
Pres	Bergstrom Donald A	420.0K	$5.36M	-
Other	Adams Brian	371.5K	$4.74M	-
Other	Rahmer Peter	276.6K	$3.53M	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Apr 9, 2026	Catinazzo Thomas73	Chief Financial Officer	Sale+OE	19,517	$13.19	$257,498.17	-4.4%	-	-
Mar 9, 2026	Catinazzo Thomas73	Chief Financial Officer	Sell	17,717	$10.06	$178,233.02	-7.1%	-	-
Jan 28, 2026	Rahmer Peter65	See Remarks	Sell	13,038	$7.71	$100,473.38	-2.3%	+70.3%	-
Jan 28, 2026	Bergstrom Donald A77	President, R&D	Sell	21,581	$7.72	$166,676.60	-2.5%	+70.3%	-
Jan 28, 2026	Catinazzo Thomas73	Chief Financial Officer	Sell	15,515	$7.71	$119,631.15	-3.0%	+70.3%	-
Jan 6, 2026	Patel Sanjiv75	President And CEO	Sell	43,168	$7.82	$337,573.76	-6.1%	+52.4%	-
Nov 3, 2025	Patel Sanjiv75	President And CEO	Sell	62,073	$7.00	$434,511.00	-8.1%	+17.4%	-
Oct 29, 2025	Rahmer Peter65	See Remarks	Sell	40,529	$7.40	$299,949.15	-5.5%	+16.3%	-
Oct 28, 2025	Catinazzo Thomas73	Chief Financial Officer	Sell	21,664	$7.29	$157,930.56	-6.5%	+0.9%	-
Oct 28, 2025	Bergstrom Donald A77	President, R&D	Sell	30,897	$7.29	$225,239.13	-5.6%	+0.9%	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC